Product Information
DALFAMPRIDINE ER 10 MG TABLET is a generic product labeled by Micro Labs Limited, priced at $0.3992 per EA under NDC 42571027560. Its NADAC has been published 377 times since Jul 17, 2019.
FDA first approved this application on Mar 11, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Micro Labs LimitedNDC
42571027560
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DALFAMPRIDINEApproval Type
Generic (ANDA)
FDA Application
ANDA210158FDA Approved
3/11/2019
TE Code
AB
On Market Since
3/21/2019
Pharmacological Classes
Price Statistics
The NADAC for DALFAMPRIDINE ER 10 MG TABLET has been published 377 times since Jul 17, 2019, and over the history we have for it it has declined 82.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3992 per EA |
|---|---|
| All-time high | $2.2175 (Sep 11, 2019) |
| All-time low | $0.3640 (May 20, 2026) |
| 52-week high | $0.4824 |
| 52-week low | $0.3640 |
| Median price | $0.5775 |
| Average price | $0.8293 |
| Largest weekly change | +65.1% (Jun 17, 2020) |
| Weeks tracked | 377 |
| Tracking since | Jul 17, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Micro Labs Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
DALFAMPRIDINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Potassium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DALFAMPRIDINE ER 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DALFAMPRIDINE ER 10 MG TABLET, manufactured by Micro Labs Limited, is $0.3992 per EA (NDC 42571027560), effective Sep 30, 2026.
How has the price of DALFAMPRIDINE ER 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for DALFAMPRIDINE ER 10 MG TABLET has declined 82.0%. It has been tracked across 377 weekly CMS publications since Jul 17, 2019.
What are the highest and lowest recorded NADAC prices for DALFAMPRIDINE ER 10 MG TABLET?
Since Jul 17, 2019, the NADAC for DALFAMPRIDINE ER 10 MG TABLET has ranged from a low of $0.3640 (May 20, 2026) to a high of $2.2175 (Sep 11, 2019), with a median of $0.5775 per EA.
Are there cheaper alternatives to DALFAMPRIDINE ER 10 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DALFAMPRIDINE ER 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DALFAMPRIDINE ER 10 MG TABLET?
DALFAMPRIDINE ER 10 MG TABLET (NDC 42571027560) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.